Active in situ immune complex glomerulonephritis using the hapten-carrier system: role of epitope density in cationic antigens

Clin Exp Immunol. 1988 Oct;74(1):121-5.

Abstract

The role of epitope density in cationic antigen was investigated in an active model of in situ immune complex glomerulonephritis (ICGN) using the hapten-carrier system. Trinitrophenol (TNP) was conjugated with variable density to cationic human immunoglobulin (C-HIgG) to yield TNP6.2-C-HIgG (low-valency antigen) and TNP31.3-C-HIgG (high-valency antigen). In rats preimmunized with TNP17.3-bovine serum albumin (BSA), endocapillary proliferative GN with proteinuria developed in rats receiving high-valency antigen. In contrast, no significant abnormalities in renal histology or urinalysis were observed when a low-valency antigen was injected. These results indicate that glomerular injury produced by hapten-specific immune reaction is affected by the number of haptenic groups conjugated to the carrier molecule (epitope density) in active in situ ICGN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / analysis
  • Epitopes / analysis*
  • Fluorescent Antibody Technique
  • Glomerulonephritis / immunology*
  • Glomerulonephritis / pathology
  • Haptens
  • Immune Complex Diseases / immunology*
  • Immunoglobulin G / immunology
  • Kidney / pathology
  • Male
  • Proteinuria
  • Rats
  • Rats, Inbred Strains
  • Trinitrobenzenes / immunology

Substances

  • Antibodies
  • Epitopes
  • Haptens
  • Immunoglobulin G
  • Trinitrobenzenes